Literature DB >> 15331877

Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke.

A Arboix1, N Cabeza, L García-Eroles, J Massons, M Oliveres, C Targa, M Balcells.   

Abstract

BACKGROUND: We hypothesized that previous transient ischemic attack (TIA) had a favorable effect on early outcome after acute nonlacunar ischemic stroke.
METHODS: Data of 1,753 consecutive patients with ischemic stroke collected from a prospective hospital-based stroke registry were studied. A comparison was made of the groups with and without previous TIA. Favorable outcome included spontaneous neurological recovery or grades 0-2 of the modified Rankin scale at hospital discharge.
RESULTS: Previous TIA occurred in 55 (11.5%) of 484 patients with lacunar stroke and in 166 (13.1%) of 1,269 patients with nonlacunar stroke. The percentage of nonlacunar ischemic stroke patients with favorable outcome was 21.7% in those with a history of TIA compared to 15% without TIA (p < 0.03). In the lacunar stroke group, differences were not significant. In the multivariate analysis, TIA was an independent predictor of spontaneous in-hospital recovery.
CONCLUSIONS: Prior TIA was associated with a favorable outcome in nonlacunar ischemic stroke, suggesting a neuroprotective effect of TIA possibly by inducing a phenomenon of ischemic tolerance allowing better recovery from a subsequent ischemic stroke.

Entities:  

Mesh:

Year:  2004        PMID: 15331877     DOI: 10.1159/000080356

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  24 in total

1.  No evidence that severity of stroke in internal carotid occlusion is related to collateral arteries.

Authors:  G E Mead; J M Wardlaw; S C Lewis; M S Dennis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-17       Impact factor: 10.154

2.  Metabolomics predicts stroke recurrence after transient ischemic attack.

Authors:  Mariona Jové; Gerard Mauri-Capdevila; Idalmis Suárez; Serafi Cambray; Jordi Sanahuja; Alejandro Quílez; Joan Farré; Ikram Benabdelhak; Reinald Pamplona; Manuel Portero-Otín; Francisco Purroy
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

Review 3.  Hypoxic conditioning and the central nervous system: A new therapeutic opportunity for brain and spinal cord injuries?

Authors:  S Baillieul; S Chacaroun; S Doutreleau; O Detante; J L Pépin; S Verges
Journal:  Exp Biol Med (Maywood)       Date:  2017-06

Review 4.  Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke.

Authors:  Adrià Arboix
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

Review 5.  Preconditioning in neuroprotection: From hypoxia to ischemia.

Authors:  Sijie Li; Adam Hafeez; Fatima Noorulla; Xiaokun Geng; Guo Shao; Changhong Ren; Guowei Lu; Heng Zhao; Yuchuan Ding; Xunming Ji
Journal:  Prog Neurobiol       Date:  2017-01-18       Impact factor: 11.685

Review 6.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 7.  Ischemic tolerance in stroke treatment.

Authors:  Nora Sandu; Jan Cornelius; Andreas Filis; Belachew Arasho; Miguel Perez-Pinzon; Bernhard Schaller
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-10

Review 8.  Secondary stroke prevention: inside the vessels and beyond.

Authors:  Matthias W Riepe; Roman Huber
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Metabolic downregulation: a key to successful neuroprotection?

Authors:  Midori Yenari; Kazuo Kitagawa; Patrick Lyden; Miguel Perez-Pinzon
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

Review 10.  Cellular and molecular neurobiology of brain preconditioning.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Mol Neurobiol       Date:  2009-01-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.